Loading
Life sciences · Journal article
Ayushdhara · November 2, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Obesity is an important modifiable contributor to chronic disease, including cardiovascular disease and type 2 diabetes. Metabolic syndrome is a clustering of cardiometabolic risk factors, including central obesity, elevated blood pressure, raised glucose and dyslipidaemia. Atisthaulya, described in Ayurveda as excessive accumulation of Meda and Mamsa dhatu, has clinical overlap with contemporary concerns about obesity and cardiometabolic risk. District-level data from Malappuram were reported to be limited. Objective: To estimate the prevalence of Atisthaulya and metabolic syndrome among adults aged 20–50 years in selected Panchayats of Malappuram district, Kerala, and describe their sociodemographic, lifestyle, anthropometric and biochemical characteristics. Methods: This cross-sectional study aimed to estimate the prevalence of Atisthaulya and metabolic syndrome among adults aged 20–50 years in selected Panchayats of Malappuram district. Three Panchayats were selected using a geographical sampling approach. A total of 1,000 participants of both sexes were recruited by cluster sampling: 333 participants from each of two Panchayats and 334 from the third. Data were collected using a structured questionnaire, anthropometric measurements, blood pressure assessment and laboratory investigations. Metabolic Syndrome was assessed using Adult Treatment Panel III (ATP III) criteria, while Atisthaulya was classified using specified Ayurvedic clinical features. Results: The manuscript reports an overall prevalence of Atisthaulya of 14.3% and metabolic syndrome of 8.5%. Within the reported metabolic syndrome group, 85.89% were aged 41–50 years and 83.34% were women. Most participants in the metabolic syndrome group reportedly did not exercise regularly (91.77%). Conclusion: The reported findings indicate a potential burden of obesity-related and cardiometabolic risk in the sampled population.